Santé & Pharma

PIU’ MEDICAL COMUNICAZIONE INTERMEDIA DURANTE IL PERIODO DI STABILIZZAZIONE

34,9M

PIU’ MEDICAL INTERIM COMMUNICATION DURING THE STABILIZATION PERIOD

269,8M

PIU’ MEDICAL PIÙ MEDICAL AMMESSA ALLE NEGOZIAZIONI SU EURONEXT GROWTH MILAN

34,9M

PIU’ MEDICAL SPA

36,8M

PLx Pharma Inc.

PMV Pharmaceuticals, Inc.

65,6M

PNV

673,6M

POD

31M

POINT Biopharma Global Inc.

POLARITYTE, INC.

POXEL

13M

PPD, Inc.

PPD, Inc.

PRA Health Sciences, Inc.

PREDILIFE

3,6M

PRIM S.A

PRIM, S.A.

227M

PRIM, S.A.

4,7B

PRO DEX INC

232,3M

PRO MEDEX

294M

PROCEPT BioRobotics Corp

1,1B

PROCYON CORP

2,3M

PROGENITY, INC.

PSYCHEMEDICS CORP

15,2M

PTC Therapeutics, INC.

5,5B

PZ Cormay S.A.

44,6M

Pacific Biosciences of California, INC.

422,7M

Pacific Health Care Organization INC

12,8M

Pacira BioSciences, Inc.

1,9B

Palatin Technologies INC

18,3M

Palisade Bio, INC.

294,5M

Panacea Biotec Limited

25,8B

Panacea Life Sciences Holdings, INC.

1,9M

Panbela Therapeutics, Inc.

485

Paragon 28, Inc.

Paratek Pharmaceuticals, Inc.

Pardes Biosciences, INC.

Park Dental Partners, Inc.

98,4M

Pasithea Therapeutics Corp.

Passage BIO, Inc.

14,1M

Patterson Companies, INC.

Paxman AB (publ)

1,4B

Paxman AB (publ)

1,1B

Peak Processing Limited

21,4M

Pear Therapeutics, Inc.

Pediatrix Medical Group, Inc.

2,1B

Peijia Medical Ltd. - B

3,3B

Pelthos Therapeutics Inc.

88,6M

Pennant Group, Inc.

1,4B

Pentixapharm Holding AG

950k